August 12, 2020 Oncology, Other methodologies, Other methodologies, Pharmacogenetics ENDGF176 Dihydropyrimidine dehydrogenase deficiency: DPYD gene Learn more By Mario Fonte 0
August 12, 2020 Oncology, Other methodologies, Other methodologies, Pharmacogenetics ENDGF177 Dihydropyrimidine dehydrogenase deficiency: DPYD gene (c.1236G>A, c.1679T>G, c.1905+1G>A and c.2846A>T) Learn more By Mario Fonte 0
August 12, 2020 Other methodologies, Pharmacogenetics ENDGF179 P450 genotyping: CYP1A2 gene (*1C, *1F) Learn more By Mario Fonte 0
August 12, 2020 Other methodologies, Pharmacogenetics ENDGF180 P450 genotyping: CYP2C19 gene (*2) Learn more By Mario Fonte 0
August 12, 2020 Other methodologies, Pharmacogenetics ENDGF181 P450 genotyping: CYP2C9 gene (*2, *3) Learn more By Mario Fonte 0
August 12, 2020 Other methodologies, Pharmacogenetics ENDGF182 P450 genotyping: CYP2D6 gene (*2N, *3, *4, *5, *6, *9, *10, *41) Learn more By Mario Fonte 0
August 12, 2020 Other methodologies, Pharmacogenetics ENDGF183 P450 genotyping: CYP3A4 gene (*1B) Learn more By Mario Fonte 0
August 12, 2020 Other methodologies, Pharmacogenetics ENDGF178 Pseudocholinesterase deficiency: BCHE gene Learn more By Mario Fonte 0
January 29, 2021 Other methodologies, Pharmacogenetics ENDGF546 Warfarin sensitivity/resistance: CYP2C9 (*2, *3) and VKORC1 (c.-1639G>A) genes Learn more By Mario Fonte 0
August 12, 2020 Other methodologies, Pharmacogenetics ENDGF185 Warfarin sensitivity/resistance: CYP2C9 gene (*2, *3) Learn more By Mario Fonte 0
